Reduce Vasculitis Relapse With Immunosuppressive Drugs
Continuing azathioprine and prednisolone past 2 years from diagnosis was superior to withholding them.
Actemra for Giant Cell Arteritis Study Data Published
The need to find an alternative to prolonged periods of steroid therapy was addressed.
Medium-Sized Vasculitides May Be Distinct Diseases
A direct comparison of their clinical characteristics helps distinguish one from another.
FDA Approves Tocilizumab for GCA
Tocilizumab in its subcutaneous form is the first-ever drug designated for giant cell arteritis which affects 230,000 people in the U.S
Diagnosing and Treating Vasculitis: an Update
Mayo Clinic’s Dr. Eric Matteson and Dr. Sharon Chung of UCSF provide an update on advances in new treatments for vasculitis.
Efficacy of Abatacept for Treating Vasculitis
Two new studies find that abatacept plus prednisone improves duration of remission for giant cell arteritis patients, but not for Takayasu’s arteritis patients.
Gastrointestinal Involvement in Systemic Vasculitis
Gastrointestinal involvement is known to be associated with primary vasculitis. But in some cases, it may be IBD with secondary vasculitis, this review shows.
EULAR Updates Vasculitis Treatment Recommendations
The European League Against Rheumatism has updated its 2009 recommendations for the management of antineutrophil cytoplasmic antibody-associated vasculitis.
IM Journal Names Top Rheumatology Reports of 2014
Top reports chosen by Annals of Internal Medicine include several on biologics for rheumatoid arthritis and psoriatic arthritis, and mechanisms for lupus and scleroderma.
FDG-PET Useful to Resolve Doubts About GCA
A systematic review finds the technique highly sensitive and specific in diagnosing giant cell arteritis, especially useful when biopsy results are equivocal.